2022 annual financial data
Entrada Therapeutics 2022 Operating margin
Direct answer
Operating margin was -384.99%.
Operating income was -97,248,000 USD and net income was -87,457,000 USD.
Operating cash flow was -93,786,000 USD.
Get free Entrada Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 25,260,000 USD
- Operating income
- -97,248,000 USD
- Net income
- -87,457,000 USD
- Operating cash flow
- -93,786,000 USD